Global And United States Lung Cancer Liquid Biopsy Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exosomes and RNA
1.2.3 CTCs and ctDNA
1.3 Market by Application
1.3.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2016-2027)
2.2 Lung Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Liquid Biopsy Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Liquid Biopsy Industry Dynamic
2.3.1 Lung Cancer Liquid Biopsy Market Trends
2.3.2 Lung Cancer Liquid Biopsy Market Drivers
2.3.3 Lung Cancer Liquid Biopsy Market Challenges
2.3.4 Lung Cancer Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue
3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2020
3.5 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type
4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application
5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Liquid Biopsy Market Size (2016-2027)
6.2 North America Lung Cancer Liquid Biopsy Market Size by Type
6.2.1 North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Application
6.3.1 North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
6.4 North America Lung Cancer Liquid Biopsy Market Size by Country
6.4.1 North America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Cancer Liquid Biopsy Market Size (2016-2027)
7.2 Europe Lung Cancer Liquid Biopsy Market Size by Type
7.2.1 Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Application
7.3.1 Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country
7.4.1 Europe Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2016-2027)
9.2 Latin America Lung Cancer Liquid Biopsy Market Size by Type
9.2.1 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Application
9.3.1 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Liquid Biopsy Market Size by Country
9.4.1 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 RainDanceTechnologies
11.1.1 RainDanceTechnologies Company Details
11.1.2 RainDanceTechnologies Business Overview
11.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Introduction
11.1.4 RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.1.5 RainDanceTechnologies Recent Development
11.2 Biocartis
11.2.1 Biocartis Company Details
11.2.2 Biocartis Business Overview
11.2.3 Biocartis Lung Cancer Liquid Biopsy Introduction
11.2.4 Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.2.5 Biocartis Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer Liquid Biopsy Introduction
11.3.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 Guardant Health
11.4.1 Guardant Health Company Details
11.4.2 Guardant Health Business Overview
11.4.3 Guardant Health Lung Cancer Liquid Biopsy Introduction
11.4.4 Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.4.5 Guardant Health Recent Development
11.5 MDxHealth
11.5.1 MDxHealth Company Details
11.5.2 MDxHealth Business Overview
11.5.3 MDxHealth Lung Cancer Liquid Biopsy Introduction
11.5.4 MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.5.5 MDxHealth Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Details
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Introduction
11.6.4 Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.6.5 Pathway Genomics Recent Development
11.7 NeoGenomics Laboraories
11.7.1 NeoGenomics Laboraories Company Details
11.7.2 NeoGenomics Laboraories Business Overview
11.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Introduction
11.7.4 NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.7.5 NeoGenomics Laboraories Recent Development
11.8 Sysmex Inostics
11.8.1 Sysmex Inostics Company Details
11.8.2 Sysmex Inostics Business Overview
11.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Introduction
11.8.4 Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.8.5 Sysmex Inostics Recent Development
11.9 Cynvenio
11.9.1 Cynvenio Company Details
11.9.2 Cynvenio Business Overview
11.9.3 Cynvenio Lung Cancer Liquid Biopsy Introduction
11.9.4 Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.9.5 Cynvenio Recent Development
11.10 Menarini Silicon Biosystems
11.10.1 Menarini Silicon Biosystems Company Details
11.10.2 Menarini Silicon Biosystems Business Overview
11.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Introduction
11.10.4 Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.10.5 Menarini Silicon Biosystems Recent Development
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Details
11.11.2 Adaptive Biotechnologies Business Overview
11.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Introduction
11.11.4 Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.11.5 Adaptive Biotechnologies Recent Development
11.12 Biocept
11.12.1 Biocept Company Details
11.12.2 Biocept Business Overview
11.12.3 Biocept Lung Cancer Liquid Biopsy Introduction
11.12.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.12.5 Biocept Recent Development
11.13 Angle plc
11.13.1 Angle plc Company Details
11.13.2 Angle plc Business Overview
11.13.3 Angle plc Lung Cancer Liquid Biopsy Introduction
11.13.4 Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2016-2021)
11.13.5 Angle plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exosomes and RNA
Table 3. Key Players of CTCs and ctDNA
Table 4. Global Lung Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lung Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lung Cancer Liquid Biopsy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lung Cancer Liquid Biopsy Market Share by Regions (2016-2021)
Table 8. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lung Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Table 10. Lung Cancer Liquid Biopsy Market Trends
Table 11. Lung Cancer Liquid Biopsy Market Drivers
Table 12. Lung Cancer Liquid Biopsy Market Challenges
Table 13. Lung Cancer Liquid Biopsy Market Restraints
Table 14. Global Lung Cancer Liquid Biopsy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biopsy Market Share by Players (2016-2021)
Table 16. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2020)
Table 17. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lung Cancer Liquid Biopsy Product Solution and Service
Table 21. Date of Enter into Lung Cancer Liquid Biopsy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Table 25. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lung Cancer Liquid Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2016-2021)
Table 29. Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lung Cancer Liquid Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 61. RainDanceTechnologies Company Details
Table 62. RainDanceTechnologies Business Overview
Table 63. RainDanceTechnologies Lung Cancer Liquid Biopsy Product
Table 64. RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 65. RainDanceTechnologies Recent Development
Table 66. Biocartis Company Details
Table 67. Biocartis Business Overview
Table 68. Biocartis Lung Cancer Liquid Biopsy Product
Table 69. Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 70. Biocartis Recent Development
Table 71. Qiagen Company Details
Table 72. Qiagen Business Overview
Table 73. Qiagen Lung Cancer Liquid Biopsy Product
Table 74. Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 75. Qiagen Recent Development
Table 76. Guardant Health Company Details
Table 77. Guardant Health Business Overview
Table 78. Guardant Health Lung Cancer Liquid Biopsy Product
Table 79. Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 80. Guardant Health Recent Development
Table 81. MDxHealth Company Details
Table 82. MDxHealth Business Overview
Table 83. MDxHealth Lung Cancer Liquid Biopsy Product
Table 84. MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 85. MDxHealth Recent Development
Table 86. Pathway Genomics Company Details
Table 87. Pathway Genomics Business Overview
Table 88. Pathway Genomics Lung Cancer Liquid Biopsy Product
Table 89. Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 90. Pathway Genomics Recent Development
Table 91. NeoGenomics Laboraories Company Details
Table 92. NeoGenomics Laboraories Business Overview
Table 93. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product
Table 94. NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 95. NeoGenomics Laboraories Recent Development
Table 96. Sysmex Inostics Company Details
Table 97. Sysmex Inostics Business Overview
Table 98. Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 99. Sysmex Inostics Recent Development
Table 100. Cynvenio Company Details
Table 101. Cynvenio Business Overview
Table 102. Cynvenio Lung Cancer Liquid Biopsy Product
Table 103. Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 104. Cynvenio Recent Development
Table 105. Menarini Silicon Biosystems Company Details
Table 106. Menarini Silicon Biosystems Business Overview
Table 107. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product
Table 108. Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 109. Menarini Silicon Biosystems Recent Development
Table 110. Adaptive Biotechnologies Company Details
Table 111. Adaptive Biotechnologies Business Overview
Table 112. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product
Table 113. Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 114. Adaptive Biotechnologies Recent Development
Table 115. Biocept Company Details
Table 116. Biocept Business Overview
Table 117. Biocept Lung Cancer Liquid Biopsy Product
Table 118. Biocept Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 119. Biocept Recent Development
Table 120. Angle plc Company Details
Table 121. Angle plc Business Overview
Table 122. Angle plc Lung Cancer Liquid Biopsy Product
Table 123. Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 124. Angle plc Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Liquid Biopsy Market Share by Type: 2020 VS 2027
Figure 2. Exosomes and RNA Features
Figure 3. CTCs and ctDNA Features
Figure 4. Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Lung Cancer Liquid Biopsy Report Years Considered
Figure 9. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lung Cancer Liquid Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lung Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2027
Figure 12. Global Lung Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Figure 13. Global Lung Cancer Liquid Biopsy Market Share by Players in 2020
Figure 14. Global Top Lung Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biopsy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2020
Figure 16. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Figure 17. Global Lung Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027)
Figure 18. North America Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 20. North America Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 21. North America Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 22. United States Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 26. Europe Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 27. Europe Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 28. Germany Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lung Cancer Liquid Biopsy Market Share by Region (2016-2027)
Figure 38. China Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 46. Latin America Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 47. Latin America Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 48. Mexico Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lung Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 54. Turkey Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lung Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. RainDanceTechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 58. Biocartis Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 59. Qiagen Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 60. Guardant Health Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 61. MDxHealth Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 62. Pathway Genomics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 63. NeoGenomics Laboraories Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 64. Sysmex Inostics Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 65. Cynvenio Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 66. Menarini Silicon Biosystems Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 67. Adaptive Biotechnologies Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 68. Biocept Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 69. Angle plc Revenue Growth Rate in Lung Cancer Liquid Biopsy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.